Find Elocalcitol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 199798-84-0, Bxl 628, Elocalcitol [inn], Bxl-628, Ro-26-9228, 2wds5f2v6q
Molecular Formula
C29H43FO2
Molecular Weight
442.6  g/mol
InChI Key
LRLWXBHFPGSUOX-GJQYOBCGSA-N
FDA UNII
2WDS5F2V6Q

Elocalcitol
Elocalcitol is a calcitriol analog for inhibition of prostate cell growth; in phase II clinical trial in patients with benign prostate hyperplasia (4/2004).
1 2D Structure

Elocalcitol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1R,3Z,5S)-3-[(2E)-2-[(3aS,7aS)-1-[(E,2S)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol
2.1.2 InChI
InChI=1S/C29H43FO2/c1-6-29(32,7-2)17-8-10-20(3)25-14-15-26-22(11-9-16-28(25,26)5)12-13-23-18-24(31)19-27(30)21(23)4/h8,12-14,17,20,24,26-27,31-32H,4,6-7,9-11,15-16,18-19H2,1-3,5H3/b17-8+,22-12+,23-13-/t20-,24+,26-,27-,28+/m0/s1
2.1.3 InChI Key
LRLWXBHFPGSUOX-GJQYOBCGSA-N
2.1.4 Canonical SMILES
CCC(CC)(C=CCC(C)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)F)O)C)O
2.1.5 Isomeric SMILES
CCC(CC)(/C=C/C[C@H](C)C1=CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)F)O)C)O
2.2 Other Identifiers
2.2.1 UNII
2WDS5F2V6Q
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Bxl-628

2. Bxl628

2.3.2 Depositor-Supplied Synonyms

1. 199798-84-0

2. Bxl 628

3. Elocalcitol [inn]

4. Bxl-628

5. Ro-26-9228

6. 2wds5f2v6q

7. Ro 26-9228

8. (1r,3z,5s)-3-[(2e)-2-[(3as,7as)-1-[(e,2s)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3h-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol

9. Bxl628

10. Unii-2wds5f2v6q

11. Elocalcitol [mart.]

12. Gtpl2785

13. Schembl12932254

14. Zha79884

15. Zinc4802676

16. 1alpha-fluoro-25-hydroxy-16,23e-diene-26,27-bishomo-20-epi-cholecalciferol

17. Akos025312296

18. Db06194

19. Hy-32345

20. Cs-0001526

21. J3.510.012a

22. E98793

23. 798e840

24. Q27077174

25. 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3

26. (1r,5s,z)-3-((e)-2-((3as,7as)-3-((s,e)-6-ethyl-6-hydroxyoct-4-en-2-yl)-3a-methyl-3a,4,5,6-tetrahydro-1h-inden-7(7ah)-ylidene)ethylidene)-5-fluoro-4-methylenecyclohexanol

27. 1s,3r,5z,7e,23e)-1-fluoro-26,27-dihomo-9,10-secocholesta-5,7,10(19),16,23-pentaene-3,25-diol

28. Cyclohexanol, 3-((1-(5-ethyl-5-hydroxy-1-methyl-3-heptenyl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4h-inden-4-ylidene)ethylidene)-5-fluoro-4-methylene-, (3as-(1(1r*,3e),3aalpha,4e(1s*,3z,5r*),7abeta))-

29. Cyclohexanol, 3-((2e)-((3as,7as)-1-((1s,3e)-5-ethyl-5-hydroxy-1-methyl-3-heptenyl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4h-inden-4-ylidene)ethylidene)-5-fluoro-4-methylene-, (1r,3z,5s)-

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 442.6 g/mol
Molecular Formula C29H43FO2
XLogP35.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count7
Exact Mass442.32470877 g/mol
Monoisotopic Mass442.32470877 g/mol
Topological Polar Surface Area40.5 Ų
Heavy Atom Count32
Formal Charge0
Complexity813
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count3
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in benign prostatic hyperplasia, urinary incontinence, prostate disorders, and infertility.


Treatment of benign prostatic hyperplasia


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty